Cargando…
Combined targeting of TGF-β1 and integrin β3 impairs lymph node metastasis in a mouse model of non-small-cell lung cancer
BACKGROUND: Transforming Growth Factor beta (TGF-β) acts as a tumor suppressor early in carcinogenesis but turns into tumor promoter in later disease stages. In fact, TGF-β is a known inducer of integrin expression by tumor cells which contributes to cancer metastatic spread and TGF-β inhibition has...
Autores principales: | Salvo, Elizabeth, Garasa, Saray, Dotor, Javier, Morales, Xabier, Peláez, Rafael, Altevogt, Peter, Rouzaut, Ana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049383/ https://www.ncbi.nlm.nih.gov/pubmed/24884715 http://dx.doi.org/10.1186/1476-4598-13-112 |
Ejemplares similares
-
β3 integrin expression is required for invadopodia-mediated ECM degradation in lung carcinoma cells
por: Peláez, Rafael, et al.
Publicado: (2017) -
CRMP2 as a Candidate Target to Interfere with Lung Cancer Cell Migration
por: Morales, Xabier, et al.
Publicado: (2021) -
ICAM-1-LFA-1 Dependent CD8+ T-Lymphocyte Aggregation in Tumor Tissue Prevents Recirculation to Draining Lymph Nodes
por: Yanguas, Alba, et al.
Publicado: (2018) -
Integrin β6 serves as an immunohistochemical marker for lymph node metastasis and promotes cell invasiveness in cholangiocarcinoma
por: Li, Zequn, et al.
Publicado: (2016) -
Targeted inactivation of β1 integrin induces β3 integrin switching, which drives breast cancer metastasis by TGF-β
por: Parvani, Jenny G., et al.
Publicado: (2013)